US Women & PrEP Working Group
The US Women and PrEP Working Group is a coalition of women from leading AIDS and women’s health organizations. The coalition advocates for a coordinated national agenda that will quickly and accurately answer questions about how the antiretroviral (ARV) drug Truvada can best be made available as an HIV prevention option for women at risk of HIV infection.
The Working Group also organizes periodic community education and outreach opportunities, including webinars and meetings at conferences, highlighting issues relevant to women and PrEP in the US.
If you’re interested in joining the group, please contact us.
Advocacy for a Coordinated National Agenda
For more on the Working Group's advocacy agenda for PrEP and women click the links below.
PrEP, Possibility, Pregnancy and Breastfeeding
Monday, October 5, 2:30pm ET
Please join the US Women and PrEP working group for a discussion on PrEP, pregnancy and breastfeeding.
- Shannon Weber - HIVEonline.org
- Jessica Terlikowski - AIDS Foundation of Chicago
- Dominika Seidman - UCSF
Click here to register.
US Women and PrEP Group Webinars
Transgender Women and PrEP. What's the latest?
Thursday, July 30, 12pm ET
The US Women and PrEP Working Group and partners hosted a webinar on the first-hand look at PrEP and transgender women - through the eyes of women prescribing it, using it, choosing not to use it, advocates calling for more research on it and policy-makers charged with integrating it into the national HIV response.
Zil Goldstein - Persist Health Project and Beth Israel Medical Center
Bub Bucklew - Research Priorities Working Group, Community Partners
Ronsa Siskind - NIAID
Moderator: Sikora, Howard Brown Health center
Click here to view the video.
Slides are available here.
How Do Women Think about HIV Risk?
Tuesday, December 16, 1pm ET
The US Women & PrEP Working Group hosted a webinar on women's perception of HIV risk and how this perception impacts care providers and PrEP as a prevention option.
Gina Brown - Office of AIDS Research, National Institutes of Health
Ariane van der Straten - Director of Women's Global Health Imperative, RTI
Sharon DeCuir - Leadership and Advocacy Coordinator, HAART (HIV/AIDS Alliance Region for Two, Inc.) - personal perspective
Moderator: Dázon Dixon Diallo, Convener, US Women and PrEP Working Group
To access post-web materials and a recording of the meeting, click here.
PrEP Me, Please!
Tuesday, September 23, 4pm ET
This webinar, hosted by the US Women & PrEP Working Group, discussed PrEP's role in women's health and safer conception. It also offered advocates the opportunity to learn more about PrEP's impact on HIV prevention and education and witness first-hand a coalition of organizations determined to increase women's access to PrEP as a prevention option.
- Shannon Weber, MSW - Director, Perinatal HIV Hotline, Bay Area Perinatal AIDS Center
- Erika Aaron, MSN, CRNP - Assistant Professor, Drexel University College of Medicine, Division of Infectious Diseases and HIV Medicine
- Caroline Watson - Volunteer Outreach for BAPAC and Pro Men
Moderator: Dázon Dixon Diallo, MPH - Founder and President, SisterLove, Inc.
PrEP @ 2 Years—and still counting women in...
Monday, June 30, 12pm ET
The US Women & PrEP Working Group, SisterLove and AVAC hosted a webinar marking the two-year anniversary of the FDA licensing of Truvada as PrEP in the US. This webinar featured updates and resources in the field and discussed how progress in getting women involved in the rollout of PrEP. There was also discussion about what we know and don’t know about women's motivations and barriers to consider daily oral PrEP as an intervention. Speakers included Karen Hoover from the US CDC, Judy Auerbach from the University of California at San Francisco, Alan McCord from Project Inform, and moderator, Dazon Dixon Diallo of SisterLove and the US Women & PrEP Working Group.
Risky Women: Disrupting Simple Notions of Women’s HIV Risk
Monday, December 9, 2013, 11-12:30 ET
The final webinar of the Fall series discussed what is known from social and behavioral science and community experience about the definitions and perceptions of HIV risk among women that are relevant to their potential PrEP use. The discussion was led by:
- Judy Auerbach, PhD, Adjunct Professor, Center for AIDS Prevention Studies, University of California, San Francisco; and Consultant to AIDS United and San Francisco AIDS Foundation (slides)
- K. Rivet Amico, PhD, Research Scientist, Center for Health Intervention and Prevention, University of Connecticut (slides)
- Joanne Keatley, MSW, Director, Center of Excellence for Transgender Health, University of California, San Francisco (slides)
- Moderator: Vignetta Charles, PhD, Senior Vice President, AIDS United
Interventions discussed during call:
- Jewkes R, Nduna M, Levin J, et al. Impact of stepping stones on incidence of HIV and HSV-2 and sexual behaviour in rural South Africa: cluster randomised controlled trial. BMJ. 2008;337:a506.
- Pettifor AE, Measham DM, Rees HV, Padian NS. Sexual Power and HIV Risk, South Africa Emerg Infect Dis. 2004.
- Kalichman SC, Simbayi LC, Cloete A, et al. Integrated gender-based violence and HIV Risk reduction intervention for South African men: results of a quasi-experimental field trial. Prevention science : the official journal of the Society for Prevention Research. Sep 2009;10(3):260-269.
PrEP-ception: Sero-discordant couples using PrEP to reduce HIV transmission risk during pregnancy
The second in a series of webinars by the US Women and PrEP Working Group discussed the possibilities and challenges associated with serodiscordant couples using PrEP to help them achieve pregnancy safely.
Audio (Poppy’s story only): MP3
Follow-Up Questions: PDF
Ready, Set, PrEP: Update on current research and rollout of PrEP for women in the US
Monday, September 16, 1-2:30 ET
The US Women and PrEP Working Group held a webinar to discuss the latest in research and rollout of PrEP for women in the US. We were joined by:
- Dr. Dawn Smith, CDC
- Dr. Sally Hodder, Rutgers New Jersey Medical School
- Dr. Sharon Hillier, University of Pittsburgh, MTN
Relevant materials from Working Group members are included below.
- Will and should women in the US use PrEP? Findings from a focus group study of at-risk, HIV-negative women in Oakland, Memphis, San Diego and Washington, DC — Judith D. Auerbach, Alyx Banyan and Maura Riordan, July 2012
- Pre-exposure Prophylaxis for the Prevention of HIV Transmission to Women in the United States — Erika Aaron and Deborah Cohan, August 2012
- Comments to the FDA’s Antiviral Drugs Advisory Committee Meeting May — Erika Aaron, May 2012
- PrEP and Women - The Well Project
- Caring for women living with HIV: gaps in the evidence - Loutfy et al., November 2012
- Improving Health Outcomes for IPV-Exposed Women Living With HIV - Gina Wingood, Ralph DiClemente, and Puja Seth, September, 2013
- PrEP appears safe for use in conception, but may not be necessary if partner is taking treatment - Roger Pebody, July, 2013
- Meeting Report: Expanding HIV Prevention Options for Women - IAS, June, 2013